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Aims: To examine the ability of different common measures of cigarette dependence to 
predict smoking cessation during pregnancy.  
Design: Secondary analysis of data from a parallel-group randomised controlled trial of 
physical activity for smoking cessation. The outcomes were biochemically validated smoking 
abstinence at 4 weeks post-quit and end-of-pregnancy.  
Setting: Women identified as smokers in antenatal clinics in 13 hospital trusts predominantly 
in Southern England, who were recruited to a smoking cessation trial.  
Participants: Of 789 pregnant smokers recruited, 784 were included in the analysis. 
Measurements: Using random effect logistic regression models, we analysed the effects of 
baseline measures of cigarette dependence, including numbers of cigarettes smoked daily, 
Fagerstrom test of cigarette dependence (FTCD) score, the two FTCD sub-scales of 
heaviness of smoking index (HSI) and non-heaviness of smoking index (non-HSI), expired 
carbon monoxide (CO) level and urges to smoke (strength and frequency) on smoking 
cessation. Associations were adjusted for significant socio-demographic/health behaviour 
predictors and trial variables, and area under the ROC curve was used to determine the 
predictive ability of the model for each measure of dependence. 
Findings: All the dependence variables predicted abstinence at 4 weeks and end-of-
pregnancy. At 4 weeks, the adjusted OR (95% CI) for a unit standard deviation increase in 
FTCD was 0.59 (0.47-0.74), expired CO 0.54 (0.41-0.71), number of cigarettes smoked per 
day 0.65 (0.51-0.84), and frequency of urges to smoke 0.79 (0.63-0.98); at end of pregnancy 
they were: 0.60 (0.45-0.81), 0.55 (0.37-0.80), 0.70 (0.49-0.98) and 0.69 (0.51-0.94), 
respectively.  HSI and non-HSI exhibited similar results to the full FTCD.  
Conclusions: Four common measures of dependence, including number of cigarettes smoked 
per day, scores for Fagerstrom test of cigarette dependence and frequency of urges, and level 
of expired CO, all predicted smoking abstinence in the short term during pregnancy and at 
end-of-pregnancy with very similar predictive validity. 
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Introduction  
Smoking in pregnancy is the main preventable cause of poor birth outcomes including 
miscarriage, still birth, prematurity, and low birth weight [1-6]. Smoking also presents 
immediate risks for the mother, including placental abruption [7], as well as the long-term 
risks reported for smokers in general. In high-income countries, the prevalence of smoking 
during pregnancy is estimated to be between 10% and 26% [8-13]. It has been shown that 
smoking cessation during pregnancy improves maternal and foetal health and birth outcomes 
[14].  
To target interventions for maternal smoking cessation appropriately, there is a need to 
identify which characteristics of smokers promote or inhibit smoking cessation during 
pregnancy [15, 16]. A literature review [17] revealed a wide range of socio-demographic, 
smoking and psychological characteristics investigated as potential predictors of smoking 
cessation during pregnancy. Socio-demographic factors that have been shown to significantly 
predict cessation during pregnancy include maternal age, being married or living with 
partner, primiparity and higher socio-economic status (income, education, housing, 
employment). Smoking related variables that have been found to significantly predict 
cessation in pregnancy include lower number of cigarettes smoked per day, and if a partner or 
house member smokes. Finally, psychological variables that have been shown to predict 
cessation in pregnancy include lower levels of depression, stress and anxiety [17, 18]. Other 
predictors of cessation include higher self-efficacy for quitting, exposure to environmental 
tobacco smoke, exposure to patient education methods, greater perceived social support, 
stressful life events in early pregnancy, ethnicity, family history of diabetes and no use of 
marijuana before the pregnancy [19-22] 
Cigarette dependence measures have been shown to be valid in non-pregnant smokers [23-
27], but little is known about their validity for predicting smoking cessation in pregnancy. For 
example, among pregnant smokers the odds of cessation have been inversely related to 
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baseline cotinine level [24] and in another study [29] scores for Fagerström Test of Cigarette 
Dependence (FTCD), urges to smoke, and withdrawal symptoms failed to predict smoking 
status two weeks following the quit date.  Therefore, in this study we examined the predictive 
validity of common measures of dependence on smoking cessation in pregnancy. As a 
demonstration of predictive validity, we expect that higher scores of these measures would be 
inversely associated with cessation. The most widely used measure of cigarette dependence is 
the FTCD [30-33], while the biochemical marker of expired carbon monoxide (CO) [34,35] 
and urge to smoke [36, 37] are also commonly used to measure dependence.  The Heaviness 
of Smoking Index HSI [38], composed of two items from the FTCD (time to first cigarette of 
the day and number of cigarettes usually smoked per day), has been shown to predict failure 
of quit attempts in non-pregnant smokers in both population-based [24, 37] and clinical 
studies [27, 31, 32, 39].  Therefore, we also examined the HSI and non-HSI (comprised of the 
other four items in the FTCD), as predictors of abstinence. Urges to smoke have also been 
reported as significant predictors of abstinence in non-pregnant smokers [37, 40-41] but have 
not been assessed in a study of long-term cessation in pregnancy. Thus, this study examined  
potential cigarette dependence related  predictors of smoking cessation at four weeks post 
quit and end-of-pregnancy in a rigorously conducted large trial of a smoking cessation 
intervention during pregnancy among women who attempted to quit. It is important to 
identify dependence variables that predict smoking abstinence during pregnancy so that we 
can better target interventions at women who most need them and better understand the 
response to interventions among women with varying levels of dependence. 
The present study aimed to contribute to the evidence for predictors of smoking cessation 
during pregnancy by employing a large clinical sample that made a definite quit attempt. This 
sample enabled a robust test of the predictive ability of baseline measures of cigarette 
dependence, when controlling for a range of socio-demographic variables, through applying a 
strict criterion for abstinence, involving continuous smoking from the quit date onwards, 
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supported by biochemical verification four weeks after the target quit date and at the end of 
pregnancy.  
Materials and methods 
Participants 
This study is based on the secondary analysis of data from a randomised controlled trial of a 
physical activity intervention for smoking cessation in pregnancy [42]. Of the 8096 recorded 
as smokers at the first antenatal clinic visit in 13 National Health Service hospitals in 
southern England, a sample of 789 women, who could be contacted, fulfilled the inclusion 
criteria and were willing to participate, were randomised, using random permuted blocks of 
random size stratified by recruitment centre in a 1:1 ratio, to either the physical activity group 
(n=394) or control. Five women were excluded, two women were enrolled twice in their 
second pregnancies (we removed their second enrolment), two women were ineligible at their 
baseline visit but had been randomised erroneously, and one woman withdrew consent before 
providing baseline data. Seven hundred and eighty four eligible participants aged 16-50 
years, with 10-24 weeks gestation, currently smoking at least one cigarette daily, and 
prepared to quit smoking one week after enrolment, were included in this analysis.  
Trial Protocol 
The full protocol for the trial, approved by the Wandsworth NHS Research Ethics 
Committee, is published elsewhere [43]. All participants provided written informed consent. 
At enrolment, participants were randomised to six sessions of behavioural support alone 
(control) or this support plus a physical activity (PA) intervention, combining 14 sessions of 
supervised treadmill exercise and PA consultations. The women were advised to be active for 
at least ten minutes at a time, progressing towards 30 minutes of activity on at least five days 
a week. All participants made a quit attempt; they began preparation for quitting at their first 
treatment session, they attempted to quit approximately one week after this first session, and 
they attended a treatment session on their quit day. 
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Baseline Measures 
The following demographic, psychological and smoking characteristics, available at baseline, 
were considered for assessment as potential predictors of smoking cessation: age, ethnicity, 
body mass index (BMI), marital status, parity, gestational age, gestational interval between 
baseline and end of pregnancy, study centre, randomisation groups (physical activity vs 
control), alcohol consumption [44], self-reports of moderate-vigorous intensity physical 
activity  (MVPA) in the previous week [45], age at full-time education, occupation,  
Edinburgh postnatal depression scale (EPDS) [46] score, partner smoking status, number of 
cigarettes smoked per day before pregnancy, number cigarettes smoked per day at baseline, 
smoking status in previous pregnancy, FTCD score [30] (plus the scores for the HSI and non-
HSI components of the FTCD), expired CO level (ppm) [35], and weekly smoking urges  
[36]. The FTCD (scored 0-10) consists of six items: number of cigarettes smoker per day  10 
or less=0, 11-20=1, 21-30=2, 31 or more=3; time to first cigarette of the day (60+ mins=0, 
31-60 mins=1, 6-30 mins=2, 0-5 mins=3); difficulty not smoking in no-smoking areas (No=0, 
Yes=1); which cigarette would the smoker most hate to give up scored (‘first of the 
morning’=1, others=0); smoke more frequently in first hours after waking (No=0, Yes=1); 
smoke when ill in bed (No=0, Yes=1). Higher FTCD scores indicate greater cigarette 
dependence. The first two FTCD items make up the Heaviness of Smoking Index (HSI, 
scored 0 to 6) [38]. Weekly smoking urges (scored 0-10) consists of the combined ratings of 
strength and frequency of urges [36, 37]. The ratings of strength are: no urges=0, slight=1, 
moderate=2, strong=3, very strong=4 and extremely strong=5; and frequency: not at all=0, a 
little of the time=1, some of the time=2, a lot of time=3, almost all the time=4 and all the 
time=5. As well as the ‘combined’ measure, we examined the frequency and strength of urges 
measures separately as predictors of abstinence. 
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Smoking cessation measures 
The outcomes were self-reported continuous smoking abstinence from quit date to 4 weeks 
post-quit and from quit date to end-of-pregnancy. Following guidelines
1
, temporary, brief 
smoking lapses of up to five cigarettes (on up to five occasions) were permitted [47]. 
Biochemical validation of self-reports was undertaken at 4 weeks post-quit and end-of-
pregnancy and concentration of either exhaled CO (<8 ppm) or salivary cotinine (<10 ng per 
millilitre) was used to validate abstinence; if both measures were available both were 
required.  
Statistical Analysis 
Baseline characteristics of the sample were summarized using descriptive statistics. The main 
aim of the analysis was to understand the association between measures of cigarette 
dependence and smoking cessation outcomes. In all the following random effect logistic 
regression analyses the dependent variables were smoking cessation at 4 weeks after the quit 
day and at end-of-pregnancy. First, we conducted analysis adjusted for the random effect of 
study centre to explore the associations between cigarette dependence  baseline variables 
(i.e., scores for the FTCD and the  HSI and non-HSI components of the HSI, number of 
cigarettes smoked per day, expired CO level, and ratings for urges to smoke) and the smoking 
cessation outcomes. The standardized z-scores of these variables were used to facilitate the 
mutual comparison of their effects sizes. Then we identified baseline socio-
demographic/health behaviour factors that were significantly associated with smoking 
cessation by using random effect logistic regression analyses. We conducted likelihood ratio 
tests to assess the statistical significance. For the continuous variables in the random effect 
                                   
1
West and colleagues (2004) guideline for assessing smoking abstinence advises using self-
report of smoking abstinence over the whole follow-up period allowing up to five cigarettes 
in total, with biochemical verification of abstinence, at least, at the end of the follow-up 
period. 
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logistic regression model, it was assumed that the log odds of smoking cessation were 
linearly related to the continuous predictor. To assess this assumption and determine whether 
each variable would be best added to the model as a continuous or as a categorical variable, 
we used the likelihood ratio test (e.g., age at leaving full-time education was divided into 
quintiles and the model fits were compared when it was fitted as a categorical variable or as a 
linear trend). 
Next, we used a series of random effect logistic regression models to examine the 
independent associations between each measure of dependence and the cessation outcomes, 
when adjusting for potential socio-demographic/health behaviour factors that were shown to 
be significantly (p<0.05) associated with smoking cessation in the univariate analysis and 
gestational interval between baseline and end of pregnancy, while allowing for the variability 
across the study centre and treatment effect.. We did not fit a model containing multiple 
measures of dependence because the measures would be expected to be correlated with each 
other leading to potential multicollinearity, and the intention of the analysis was to assess 
whether all these measures predict smoking cessation outcomes rather than assessing the 
independence of their effects. We used adjusted odds ratios (OR, 95% confidence interval 
(CI)) and area under the ROC curve as a post-estimation measure of model fit to determine 
which of the predictors provide higher adjusted effect size and predictive validity. To 
examine whether the effect of the HSI and non-HSI is similar to FTCD, we compared their 
adjusted results from the models.  
For 149 (19%) of the participants at 4 weeks post-quit and 45 (5.7%) at end of pregnancy, 
smoking status was not available and it was assumed that they are smoking [47]. As a 
sensitivity analysis, to verify the results obtained in the above analyses, we conducted 
multiple imputation analyses, which assume instead that data are missing at random.  Missing 
smoking abstinence status was replaced by imputed values using chained equations [48, 49] 
of logistic regression for smoking cessations at the two follow-up times. The baseline 
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variables of randomization groups, age at leaving full-time education, married or living with 
partner, women with partner who  smoke, number of cigarettes smoked daily before 
pregnancy, FTCD score, any current alcohol use and self-reporting MVPA >150 minutes per 
week and study centre were used as explanatory variables in the imputation models. Three 
missing values in CO were also replaced by imputed values using linear regression models in 
the chained equations. We created 20 imputed datasets and conducted the same analyses as 
above to explore the predictors of smoking cessation in the imputed datasets. The imputation-
specific results of the predictors were combined using Rubin’s rules [50]. All statistical 
analyses were conducted using Stata, version 12.   
Results 
Baseline characteristics 
A summary of the baseline characteristics and smoking abstinence of the sample is provided 
in Table 1. Seven-hundred and eighty-four participants were included in the analysis, 111 
(14%) and 55 (7%) achieved continuous abstinence at 4 weeks and at the end of pregnancy, 
respectively. The participants were on average 28 years old and 16 weeks pregnant, the 
majority were married or living with partner, Caucasian, and primiparity. Before pregnancy 
all participants were reasonably heavy smokers, smoking a median of 20 cigarettes per day, 
and almost half had smoked in a previous pregnancy. At baseline, they still smoked a median 
of 10 cigarettes per day. At baseline, a quarter reported drinking any alcohol, over two thirds 
reported > 150 minutes weekly of moderate-vigorous intensity physical activity. For the 
dependence measures, there was evidence of multi-collinearity, such that the correlation 
coefficients between FTCD score and number of cigarettes smoked per day, expired CO 
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Random effect logistic analysis to explore the predictors 
In the univariate regression analyses (see Table 3), the significant cigarette dependence-
related predictors of smoking abstinence at both 4 weeks and end-of-pregnancy were: lower 
score for the FTCD and its two components (i.e., HSI and non-HSI), lower number of 
cigarettes smoked daily, lower expired CO level, and lower score for urges to smoke (for 
both ‘combined’ measure and for separate measures for frequency and strength of urges). 
When we assessed whether all the continuous independent variables were appropriately fitted 
as linear effects in the logistic regression analyses, the likelihood ratio test suggested no 
evidence of departure from linear effects.  
Of the socio-demographic/health behaviour variables, higher age at leaving full-time 
education and married or living with partner were significantly associated with smoking 
abstinence at both 4 weeks and end-of-pregnancy; self-reporting MVPA >150 minutes per 
week reached the 10% level of significance for end-of-pregnancy abstinence and was 
significant at the 5% level for 4 weeks, gestational interval between baseline and end of 
pregnancy approached significance at end of pregnancy (see table 2). Therefore we adjusted 
the effect of each cigarette dependence related predictor for these four variables while also 
allowing for variability across the study centres and treatment effect in the models (see Table 
3).   
Multiple random effect logistic regression analyses for each of the dependence measures 
In multiple logistic regression analyses, each measure of cigarette dependence remained as a 
significant predictor of smoking abstinence at 4 weeks. Adjusted OR (95% CI) for a unit 
standard deviation increase in FTCD score was 0.59 (0.47-0.74), HSI 0.64 (0.51-0.79), non-
HSI 0.64 (0.51-0.79), expired CO 0.54 (0.41-0.71), number of cigarettes smoked per day 0.65 
(0.51-0.84) and frequency of urges to smoke 0.79 (0.63-0.98); and at end-of-pregnancy for 
FTCD 0.60 (0.45-0.81), HSI 0.65 (0.48-0.87), non-HSI 0.65 (0.48-0.88), expired CO 0.55 
(0.37-0.80), number of cigarettes smoked per day 0.70 (0.49-0.98) and frequency of urges to 
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smoke 0.69 (0.51-0.93). The combined score of frequency and strength of urges to smoke 
was also a significant predictor of abstinence at end-of-pregnancy and approached 
significance at 4 weeks (see Table 3) while strength of urges to smoke did not significantly 
predict abstinence at either time point. In all cases, higher levels of the measures of cigarette 
dependence were associated with worse outcomes for abstinence. The values of area under 
the ROC curve for the models performance showed that the predictive validity for all the 
dependence measures was very similar (see Table 3).  
Sensitivity analyses using multiple imputations 
When we used multiple imputations as an alternative way of dealing with missing outcomes 
data, the results for all analyses were very similar. In particular at end of pregnancy, the 
adjusted pooled OR (95% CI) for each association of the scores for FTCD and its two sub-
scales (i.e., HSI and non-HSI), expired CO level, number of cigarettes smoked daily and the 
score for urges to smoke were: 0.58 (0.43-0.78), 0.61 (0.45-0.83), 0.64 (0.48-0.86), 0.53 
(0.36-0.78), 0.68 (0.48-0.96) and 0.74 (0.55-0.98), respectively.  
Discussion 
Cigarette dependence, measured by the FTCD, or by its HSI or non-HSI components, expired 
CO level, cigarettes consumption or frequency of urges to smoke significantly predicted 
smoking cessation at 4 weeks post-quit during pregnancy and at end-of-pregnancy.  
The finding for FTCD predicting abstinence is consistent for observations with non-
pregnant smokers [23, 27, 31]. In our study, the predictive ability of the two components of 
FTCD (i.e., HSI and non-HSI) and their effect sizes were similar to FTCD; therefore, for 
economy, it might be better to use the HSI, composed of only two items, for assessing 
cigarette dependency in pregnant smokers. The finding that lower expired CO levels 
predicted cessation is consistent with the previous finding for saliva cotinine [28], another 
biochemical marker of abstinence, and for CO levels predicting abstinence at 6 months 
postpartum [51], as well as with findings for non-pregnant smokers [34]. The finding for 
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number of cigarettes smoked per day is consistent with the results of lower number of 
cigarettes smoked per day before pregnancy predicting cessation [18]. Thus, number of 
cigarettes smoked per day or expired CO may also be considered as valid brief predictors of 
smoking cessation during pregnancy. The result for number of cigarettes smoked per day is 
important in pregnancy as almost all women smokers who do not quit significantly reduce 
their smoking rate when they find out they are pregnant (by about 50% in this study). Thus, 
despite serious cutting down, the smoking rate still predicted abstinence. Urges to smoke 
have not been previously tested as a predictor of smoking cessation during pregnancy and in 
this study frequency of urges to smoke showed significant results at the two times and the 
combined score for urges was also significant at end-of-pregnancy, which is consistent with 
the results for studies in non-pregnant populations [37, 40, 41].  
Our review of the literature found that data for the majority of studies reporting predictors 
of smoking cessation in pregnancy were from observational studies and only a few used data 
from clinical trials. Of the studies which used biochemically-validated trial data, only two 
had a large sample size. Power analysis was not conducted for this study as it was based on 
secondary analysis, but our study had a large sample size with biochemically validated 
continuous smoking cessation from quit day through to the end of pregnancy, with all 
participants making a quit attempt. Thus, our study was rigorously conducted, using a strict 
criterion for abstinence, and the use of a strict abstinence criterion is important when testing 
associations with factors promoting or undermining success of a quit attempt. Weaker 
outcome measures, such as point prevalence abstinence, are less useful because someone can 
have a full relapse back to smoking on one or more occasions and still be counted as 
abstinent, thus blurring the distinction between predicting quit attempts and quit success. The 
quit rate of 7% in this study was lower than in many previous pregnancy trials, examining 
predictors, with less rigorous abstinence criterion, but was similar to a study using 
comparable abstinence criterion [28]. Our study had a large sample size with greater power 
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for the analyses compared with most previous studies. We used careful multivariable analysis 
methods, with an efficient sensitivity analysis for missing smoking status using multiple 
imputations, which investigated adjusted associations of the measure of cigarettes 
dependence with abstinence. Compared with most previous studies, we included smokers 
with a wider range of levels of cigarette dependence (with eligible women only needing to be 
smoking at least one cigarette a day at baseline); therefore, as regards dependence, the 
findings are likely to be applicable to pregnant smokers in general. 
This study is potentially limited in terms of the representativeness of the sample. First, the 
participants were predominantly recruited in London where the smoking rates tend to be 
lower than the rest of the country. Secondly, some of the women recorded as smokers at the 
antenatal clinics could not be contacted, of those who were contacted some declined the offer 
of joining the study, and some were excluded due to the exclusion criteria of the trial, 
although there were few exclusion criteria [43]. We were unable to compare the 
characteristics of those who were recruited with those who were not. We recruited women 
who mostly reported being physically active at baseline, and who, therefore, might be more 
motivated to quit than less active women; this is likely to be because active women were 
attracted to a trial promoting physical activity in a healthcare setting. 10% of women 
recorded as smokers at the first antenatal booking visit were recruited, which was the target 
recruitment rate and is similar to rates for other large UK trials of smoking cessation in 
pregnancy [52, 53]. Quit rates were lower than for pregnancy trials with less rigorous 
outcome measures but were similar to those for studies using comparable outcomes [4]. The 
women were generally representative of women who smoke [54] and the findings are likely 
to be generalisable to primary and secondary care settings. 
We have reported elsewhere [42] that there was no significant effect of the multi-session 
treatment on smoking cessation; however we adjusted the results for the treatment effect in 
this study.  The intervention group had to change two behaviours (i.e., smoking and physical 
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activity) simultaneously, while also coping with being pregnant and attending multiple 
treatment sessions; this could have a negative impact on cessation, which may then have an 
effect on the predictive ability of the dependency measures. Although this study considered a 
broad range of variables that might have an impact on smoking cessation, there are other 
variables which we did not include, which have been found to predict cessation in pregnancy  
and which might be important, such as whether the pregnancy is planned, exposure to 
environmental tobacco smoke,  exposure to patient education methods, perceived social 
support, stressful life events in early pregnancy, use of illicit substances before pregnancy, 
motivation to quit, and nausea during pregnancy [19-22].  
These findings are important for public health policy as they highlight the importance of 
cigarette dependence for smoking cessation in pregnancy, demonstrate that multiple facets of 
dependence are likely to play a role in cessation, and identify dependence measures that are 
clinically quick to administer to tailor cessation treatments. As cigarette dependence appears 
to be a predictor of smoking cessation during pregnancy, interventions need to focus on  
supporting quit attempts among those who seek treatment and are more highly dependent 
(e.g., through helping women avoid and manage urges to smoke). Assessment of dependence 
during pregnancy is crucial so that appropriate support is provided to those women who are 
most dependent, with increased intensity of support, including higher doses and longer 
durations of nicotine replacement, for those with higher dependence [52]. The finding that the 
non-HSI part of the FTCD was predictive of abstinence suggests that, besides the commonly 
used HSI, the non-HSI may also be important.  
Conclusion 
These findings show that, in a trial of a smoking cessation intervention, higher levels of 
several common baseline measures of cigarette dependence, including number of cigarettes 
smoked per day, scores for FTCD and frequency of urges, and level of expired CO, all 
predicted smoking abstinence in the short term during pregnancy and at end-of-pregnancy 
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with very similar predictive validity. In research studies or in clinical settings, it may be most 
practicable to include either of the brief components of FTCD (i.e., HSI and non-HSI) rather 
than the full FTCD. Studies are needed to investigate these and other measures of cigarette 
dependence as predictors of smoking abstinence in further trials and in population-based 
studies 
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2 Were excluded from the analysis 
owing to enrolling twice. 
 
1 Was excluded from the analysis 
owing no baseline data. 
 
2 Were excluded from the analysis 
owing to not meeting inclusion criteria 
at baseline visit. 
 
395 Were assigned to and received 
behavioural support alone (control) 
 
53 Were lost to follow-up and were 
assumed to be smoking:    
   15 were fetal/infant deaths. 
 
 
394 Were assigned to behavioural 
support plus physical activity 
intervention (intervention group) 
 
1 withdrew consent before receiving 
any intervention.  
 
393 Received behavioural support plus 
physical activity intervention. 
 
35 Were lost to follow-up and were 
assumed to be smoking: 
      9 Were fetal/infant deaths. 
 
 
789 Underwent randomisation 
784 women were included in the 
analyses for predictors of smoking 
cessation during pregnancy. 
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Table 1: Baseline characteristics of the sample  
Variables  (N = 784) 
Mean (SD) 
Age – yr  27.5 (6.3) 
Age at leaving full-time education – yr
a
  17·7 (2.9) 
Weight – kg 70.0 (15.0) 
Body Mass Index  - kg/m
2b
  26.1 (5.3) 
Gestational age – wks                  15.6 (3.3) 
Gestational interval between baseline and end of pregnancy-wks 23.3 (4.0) 
 Median (IQR) 
 
Number of cigarettes smoked daily before pregnancy  20 (12-20) 
Number of cigarettes smoked per day at baseline  10 (5-13 
Fagerström Test of Cigarette Dependence score 4 (2-5) 
Heaviness of smoking index score
c
 2 (1-3) 
Non-Heaviness of smoking index score
d
 2 (1-3) 
Expired carbon monoxide (CO) level – ppm
e
 10 (6-14) 
Urge to smoke score
f
 6 (4-8) 
Frequency of urge to smoke 3 (2-4) 
Strength of urge to smoke 3 (2-4) 
Self-reported of weekly MVPA– mins  210·0 (130-355) 
 no. (%) 
 
Randomisation group-(physical activity) 391 (49.9) 
Married or living with partner 451 (58) 
Women with partner who smoke   511 (65.2) 
Caucasian
g
 607 (77) 
Professional/managerial occupation 99 (13) 
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Smoked in a previous pregnancy  379 (48) 
Edinburgh Post-natal Depression Scale score > 15 83 (10·6) 
Self-reporting MVPA >150 minutes per week  548 (69·9) 
Primiparity
h
 420 (53.6) 
Previous preterm birth
i
 129 (16·5) 
Any current alcohol use  201 (25.6) 
MVPA= moderate-vigorous intensity physical activity 
IQR:  interquartile range. 
a
 For 41 women, current age was considered as age at full time education as they were still in 
full-time education. 
b 
For three women, weight/BMI at their first antenatal booking visit was used as baseline 
weight/BMI as it was not recorded for them at baseline. 
c
 Composed of two Fagerström Test of Cigarette Dependence items (i.e., time to first 
cigarette of the day and number of cigarettes usually smoked per day). 
d
 Comprising of four Fagerström Test of Cigarette Dependence items other than the two items 
of HSI. 
e
 CO was not recorded for three  participants. 
f
 Urge to smoke score= Frequency of urges + Strength of urges 
g
 Race or ethnic group was self-reported and categorized according to standard UK census 
categories. 
h
 Primiparity was defined as the 1
st
 time pregnancy progressing beyond 24 weeks. 
i
 Previous preterm birth was defined as any previous pregnancy that lasted from 24 to 37 
weeks.  
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Table 2: Random effect logistic regression analyses for socio-demographic/health 




Measures 4 Weeks post-quit End of pregnancy 
OR (95% CI) p-values OR (95% CI) p-values 
Age – yr
c
  1.02 (0.99, 1.06) 0.172 1.02 (0.98, 1.06) 0.377 




1.07 (1.02, 1.14) 0.021 1.10 (1.01, 1.17) 0.022 
Body Mass Index  - kg/m
2ce
 1.00 (0.97, 1.04) 0.779 1.02 (0.97, 1.07) 0.475 
Married or living with partner 2.01 (1.29, 3.12) 0.002 1.91 (1.04, 3.49) 0.036 
Primiparity
f
 1.13 (0.75, 1.70) 0.549 1.20 (0.69, 2.10) 0.520 
Women with partner who smoke 0.86 (0.54, 1.37) 0.529 0.96 (0.51, 1.83) 0.909 
Edinburgh Post-natal Depression 
Scale score > 15 
1.20 (0.63, 2.28) 0.573 0.84 (0.32, 2.17) 0.713 
Self-reporting MVPA >150 
minutes per week  
2.64 (1.53, 4.57) <0.001 1.77 (0.89, 3.50) 0.102 
Alcohol use  1.17 (0.74, 1.83) 0.506 1.68 (0.94  2.99) 0.080 
Gestational age – wk                   1.00 (0.94, 1.06) 0.917 0.95 (0.87,  1.04) 0.248 
Gestational interval between 
baseline and end of pregnancy 
1.00 (0.95, 1.05) 0.923 1.08 (1.00, 1.16) 0.051 
Living in a deprived Area 0.75 (0.50, 1.14) 0.180 1.08 (0.61, 1.91) 0.788 
Caucasian
g
 0.87 (0.54, 1.40) 0.565 1.05 (0.54, 2.050) 0.879 
Occupation (managerial vs. all 
others) 
1.09 (0.60, 1.99) 0.765 1.37 (0.65, 2.91) 0.406 
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MVPA= moderate-vigorous intensity physical activity 
a
 Adjusted for the random effect of study centre 
b
 For 149 and 44 participants at 4 weeks post quit and end of pregnancy, respectively, the 
outcome was missing and it was assumed that they are smoking. 
OR (95% CIs) =Odds ratio (95% confidence intervals) 
c
 The odds ratio reflect an effect of per unit change of the independent variable on smoking 
cessation outcome.   
d
 For 41 women, current age was considered as age at full time education as they were still in 
full-time education. 
e 
For three women, weight/body mass index at their first antenatal booking visit was used as 
baseline weight/ body mass index as it was not recorded for them at baseline. 
f
 Primiparity was defined as the 1
st
 time pregnancy progressing beyond 24 weeks. 
g
 Race or ethnic group was self-reported and categorized according to standard U.K census 
categories.
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Table 3: Random effect logistic regression analyses to assess the ability of each cigarette dependence related measure
 




 Random effect logistic regression analyses
b
 Random effect multiple logistic regression models
c
 
Measures 4 Weeks post-quit End of pregnancy 4 Weeks post-quit End of pregnancy 
OR (95% CI)
d
 OR (95% CI)
d


















0.56 (0.45, 0.70) 0.58 (0.43, 0.77) 0.59 (0.47, 0.74) 0.702  
(0.648-0.756) 
0.60 (0.45, 0.81) 
 
0.673  
(0.617, 0 .730) 




0.59 (0.48, 0.73) 0.60 (0.45, 0.80) 0.63 (0.51, 0.79) 0.692  
(0.636, 0.747) 








0.63 (0.51, 0.78) 0.64 (0.48, 0.86) 0.64 (0.51, 0.79)  0.694 
(0.641, 0.747) 
0.65 (0.48, 0.88) 0.660  
(0.504, 0.717) 
Expired carbon monoxide 
(CO) level – ppm
g 
 
0.55 (0.42, 0.72) 0.55 (0.38, 0.79) 0.54 (0.41, 0.71) 0.711  
(0.659, 0.763) 




Number of cigarettes smoked 
per day at baseline 
0.62 (0.48, 0.80) 0.66 (0.47, 0.92) 0.65 (0.51, 0.84) 0.690  
(0.633, 0.746) 
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Urge to smoke score
h
 0.78 (0.63, 0.96) 0.66 (0.50, 0.88) 0.82 (0.66, 1.01) 0.672  
(0.617, 0.727) 
0.69 (0.51, 0.93) 0.630  
(0.572, 0.687) 
Frequency of urge to smoke 0.74 (0.60, 0.91) 0.66 (0.49, 0.88) 0.79 (0.63, 0.98) 0.675  
(0.620, 0.730) 
0.69 (0.51, 0.94) 0.637 
(0.580, 0.693) 
Strength of urge to smoke 0.87 (0.71, 1.07) 0.74 (0.56, 0.98) 0.90 (0.72, 1.11) 0.664  
(0.610, 0.719) 




 For 149 and 44 participants at 4 weeks post quit and end of pregnancy, respectively, the outcome was missing and it was assumed that they are smoking. 
b
 Adjusted for the random effect of study centre
 
c 
Adjusted for the  potential confounders of age at leaving full-time education, married or living with partner,  self-reporting MVPA≥150 minutes per week, 
randomisation groups, gestational interval between baseline and end of pregnancy, and random effect of study centre in the random effect logistic regression 
model. The mixed effect multiple logistic models are separate models for each dependence measure and do not include the other dependence measures. 
d
OR (95% CIs): the odds ratios (95% confidence intervals) reflect lower odds of abstinence for per unit standard deviation increase in values of the 
predictors. 
e
 Composed of the two Fagerström Test of Cigarette Dependence items (i.e., time to first cigarette of the day and number of cigarettes usually smoked per 
day). 
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f
 Comprised of the four Fagerström Test of Cigarette Dependence items other than the two items of Heaviness of Smoking Index. 
g
 CO was not recorded for three participants. 
h
 Weekly urges to smoke score= Composite of frequency of urges plus strength of urges. 
 
